Previous Article | Next Article ![]()
Journal of Clinical Microbiology, March 2004, p. 1082-1088, Vol. 42, No. 3
0095-1137/04/$08.00+0 DOI: 10.1128/JCM.42.3.1082-1088.2004
Copyright © 2004, American Society for Microbiology. All Rights Reserved.
Department of Parasitology,1 Animal Laboratory for Medical Research, Asahikawa Medical College, Asahikawa,4 Surgical Center, Hokkaido University Hospital, Sapporo, Japan,5 Department of Parasitology, Xinjiang Medical University, Urumqi,2 Sichuan Institute of Parasitic Diseases, Chengdu, China,3 Université de Franche-Comte, World Health Organization Collaborating Center on Prevention and Treatment of Human Echinococcosis, Besançon, France,6 Veterinary Clinical Center, University of Melbourne, Melbourne, Victoria, Australia,7 Bioscience Research Institute, School of Environment and Life Science, University of Salford, Greater Manchester, United Kingdom8
Received 16 September 2003/ Returned for modification 5 November 2003/ Accepted 24 November 2003
Full-length cDNA and genomic DNA encoding an 8-kDa subunit of antigen B from Echinococcus multilocularis (designated EmAgB8/1) were isolated from an E. multilocularis metacestode cDNA library and a protoscolex genomic DNA library, respectively. The open reading frame of the cDNA clone encodes a polypeptide comprising 85 amino acids with a 20-amino-acid NH2-terminal signal sequence, which was confirmed following N-terminal sequencing of the native antigen. Reverse transcription-PCR analysis revealed that the clone encoding EmAgB8/1 is predominantly transcribed in larval E. multilocularis. The gene consists of two exons (encoding the signal sequence and mature protein) separated by a 91-bp intron. The mature form was expressed in Escherichia coli, and its antigenic reactivity was compared with that of a counterpart, an 8-kDa subunit of antigen B from Echinococcus granulosus (EgAgB8/1) by Western blotting and enzyme-linked immunosorbent assay (ELISA) with serum samples from patients confirmed to have cystic echinococcosis (CE) and alveolar echinococcosis (AE). Recombinant EmAgB8/1 showed positive reactions in Western blots with 81.3% (65 of 80) of serum samples from CE patients and 40.6% (26 of 64) of serum samples from AE patients, while recombinant EgAgB8/1 showed positive reactions with 86% (43 of 50) and 42% (19 of 45) of the serum samples from these CE and AE patients, respectively. By the ELISA, both EmAgB8/1 and EgAgB8/1 exhibited similar positive reactions with 88% (44 of 50) of serum samples from CE patients and 37.8% (17 of 45) serum samples from AE patients. Statistical analysis revealed that the sensitivity of EmAgB8/1 was comparable to that of EgAgB8/1 for the serodiagnosis of echinococcal diseases. There was no cross-reaction with sera from patients with cysticercosis, which often cross-react when native antigens are used for serodiagnosis.
This article has been cited by other articles:
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»